Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 110.49 million compared to INR 141.03 million a year ago. Revenue was INR 112.97 million compared to INR 141.68 million a year ago. Net income was INR 1.71 million compared to INR 30.17 million a year ago. Basic earnings per share from continuing operations was INR 0.17 compared to INR 2.93 a year ago. Diluted earnings per share from continuing operations was INR 0.17 compared to INR 2.93 a year ago.